Patents by Inventor AnnaCarin Wallgren

AnnaCarin Wallgren has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition for inhibiting tumor cell proliferation
    Patent number: 9034317
    Abstract: This invention pertains to cancer immunotherapy, by providing a proinflammatory dendritic cell (DC), which has been stimulated to maturation ex vivo by specific treatment, a method for such treatment and a composition comprising the proinflammatory DC. The DC may be used as a cell based immunotherapy for inhibiting tumor cell proliferation.
    Type: Grant
    Filed: February 10, 2011
    Date of Patent: May 19, 2015
    Assignee: IMMUNICUM AB
    Inventors: Alex Karlsson-Parra, Bengt Andersson, AnnaCarin Wallgren
  • METHOD AND COMPOSITION FOR PRODUCING A CELLULAR ALLOGENEIC VACCINE
    Publication number: 20140141046
    Abstract: The present invention relates to a method for the production of a cellular allogeneic vaccine, which is based upon an allogeneic APC, comprising the following steps: isolation of an APC from a subject or providing an APC already established and/or isolated from a myeloid leukemia cell line, and modifying the APC with an antigen using any of the following methods: pulsing, transfection, infection or fusion; treatment using an agent capable of removing sialic acid on cell surfaces; and optionally culturing the APC in a suitable medium, an allogeneic vaccine obtainable by the above method, a composition comprising said vaccine and a pharmaceutically acceptable carrier and therapeutic use of said vaccine or said composition.
    Type: Application
    Filed: January 27, 2014
    Publication date: May 22, 2014
    Applicant: IMMUNICUM AB
    Inventors: Alex KARLSSON-PARRA, AnnaCarin WALLGREN, Bengt ANDERSSON
  • Method and composition for producing a cellular allogeneic vaccine
    Patent number: 8673296
    Abstract: The present invention relates to a method for the production of a cellular allogeneic vaccine, which is based upon an allogeneic APC, comprising the following steps: isolation of an APC from a subject or providing an APC already established and/or isolated from a myeloid leukemia cell line, and modifying the APC with an antigen using any of the following methods: pulsing, transfection, infection or fusion; treatment using an agent capable of removing sialic acid on cell surfaces; and optionally culturing the APC in a suitable medium, an allogeneic vaccine obtainable by the above method, a composition comprising said vaccine and a pharmaceutically acceptable carrier and therapeutic use of said vaccine or said composition.
    Type: Grant
    Filed: November 24, 2006
    Date of Patent: March 18, 2014
    Assignee: Immunicum AB
    Inventors: Alex Karlsson-Parra, AnnaCarin Wallgren, Bengt Andersson
  • COMPOSITION FOR INHIBITING TUMOR CELL PROLIFERATION
    Publication number: 20120328662
    Abstract: This invention pertains to cancer immunotherapy, by providing a proinflammatory dendritic cell (DC), which has been stimulated to maturation ex vivo by specific treatment, a method for such treatment and a composition comprising the proinflammatory DC. The DC may be used as a cell based immunotherapy for inhibiting tumor cell proliferation.
    Type: Application
    Filed: February 10, 2011
    Publication date: December 27, 2012
    Applicant: Immunicum AB
    Inventors: Alex Karlsson-Parra, Bengt Andersson, AnnaCarin Wallgren
  • Method and composition for producing a cellular allogeneic vaccine
    Publication number: 20070134219
    Abstract: The present invention relates to a method for the production of a cellular allogeneic vaccine, which is based upon an allogeneic APC, comprising the following steps: isolation of an APC from a subject or providing an APC already established and/or isolated from a myeloid leukemia cell line, and modifying the APC with an antigen using any of the following methods: pulsing, transfection, infection or fusion; treatment using an agent capable of removing sialic acid on cell surfaces; and optionally culturing the APC in a suitable medium, an allogeneic vaccine obtainable by the above method, a composition comprising said vaccine and a pharmaceutically acceptable carrier and therapeutic use of said vaccine or said composition.
    Type: Application
    Filed: November 24, 2006
    Publication date: June 14, 2007
    Applicant: IMMUNICUM AB
    Inventors: Alex Karlsson-Parra, AnnaCarin Wallgren, Bengt Andersson